The CLEVER Study - Coreg And Left Ventricular Mass Regression

Clinical trial NCT00108082 · COMPLETED

Trial details

NCT number: NCT00108082
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypertrophy, Left Ventricular

Start date: 2005-01-01
Primary completion: 2008-08-01
Enrollment: 287

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.